Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist.
Product attributes
Brand: Chinqesen
Model: 2023788-19-2
Place of origin: Shanghai
Custom properties
Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist.
Trading information
Minimum Order: 10mg/vial, 10 bottles/box, MOQ 2 boxes
Price: 300usd/box，including shipping
Payment: T/T, Bitcoin, Western Union, Credit Card, Bank Transfer, PayPal
Delivery: 1000000 boxes/week
Delivery: Ships immediately after payment received
Regular packing: 10mg/vial, 10 bottles/box
